EAPIF
Price
$2.90
Change
-$0.12 (-3.97%)
Updated
Feb 25 closing price
Capitalization
1.11B
STEK
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Apr 3 closing price
Capitalization
2.98M
Ad is loading...

EAPIF vs STEK

Header iconEAPIF vs STEK Comparison
Open Charts EAPIF vs STEKBanner chart's image
EUROAPI SA
Price$2.90
Change-$0.12 (-3.97%)
Volume$3K
Capitalization1.11B
Stemtech
Price$0.03
Change-$0.00 (-0.00%)
Volume$198.48K
Capitalization2.98M
EAPIF vs STEK Comparison Chart
Loading...
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EAPIF vs. STEK commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAPIF is a Hold and STEK is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (EAPIF: $2.90 vs. STEK: $0.03)
Brand notoriety: EAPIF and STEK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EAPIF: 160% vs. STEK: 99%
Market capitalization -- EAPIF: $1.11B vs. STEK: $2.98M
EAPIF [@Pharmaceuticals: Other] is valued at $1.11B. STEK’s [@Pharmaceuticals: Other] market capitalization is $2.98M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EAPIF’s FA Score shows that 0 FA rating(s) are green whileSTEK’s FA Score has 0 green FA rating(s).

  • EAPIF’s FA Score: 0 green, 5 red.
  • STEK’s FA Score: 0 green, 5 red.
According to our system of comparison, EAPIF is a better buy in the long-term than STEK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STEK’s TA Score shows that 4 TA indicator(s) are bullish.

  • STEK’s TA Score: 4 bullish, 5 bearish.

Price Growth

EAPIF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while STEK (@Pharmaceuticals: Other) price change was -13.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.92%. For the same industry, the average monthly price growth was -4.08%, and the average quarterly price growth was -12.02%.

Reported Earning Dates

STEK is expected to report earnings on Apr 17, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (-4.92% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EAPIF($1.11B) has a higher market cap than STEK($2.98M). EAPIF has higher P/E ratio than STEK: EAPIF (476.19) vs STEK (1.05). EAPIF YTD gains are higher at: -3.333 vs. STEK (-37.365). EAPIF has higher annual earnings (EBITDA): 62.7M vs. STEK (-4.36M). EAPIF has higher revenues than STEK: EAPIF (893M) vs STEK (4.54M).
EAPIFSTEKEAPIF / STEK
Capitalization1.11B2.98M37,340%
EBITDA62.7M-4.36M-1,438%
Gain YTD-3.333-37.3659%
P/E Ratio476.191.0545,548%
Revenue893M4.54M19,687%
Total CashN/A343K-
Total DebtN/A1.15M-
FUNDAMENTALS RATINGS
STEK: Fundamental Ratings
STEK
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STEK
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 23 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFEAX49.63N/A
N/A
Janus Henderson European Focus A
SMAPX11.05N/A
N/A
Westwood Salient MLP & Engy Infras A
JSCGX19.46N/A
N/A
Jacob Small Cap Growth Investor
SVFKX78.27N/A
N/A
Smead Value R2
MAIHX17.26N/A
N/A
Morgan Stanley Inst Passport ovrs eq IR

EAPIF and

Correlation & Price change

A.I.dvisor tells us that EAPIF and HLN have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
HLN - EAPIF
14%
Poorly correlated
+2.85%
HLNCF - EAPIF
11%
Poorly correlated
-0.39%
IXHL - EAPIF
7%
Poorly correlated
-1.35%
STEK - EAPIF
6%
Poorly correlated
-6.45%
CLSH - EAPIF
4%
Poorly correlated
-6.00%
More

STEK and

Correlation & Price change

A.I.dvisor tells us that STEK and CNADF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STEK and CNADF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STEK
1D Price
Change %
STEK100%
-6.45%
CNADF - STEK
25%
Poorly correlated
N/A
BFRI - STEK
12%
Poorly correlated
-1.70%
HLNCF - STEK
11%
Poorly correlated
-0.39%
PLSH - STEK
8%
Poorly correlated
N/A
EAPIF - STEK
6%
Poorly correlated
N/A
More